Detalhe da pesquisa
1.
An Immune Atlas of Clear Cell Renal Cell Carcinoma.
Cell
; 169(4): 736-749.e18, 2017 05 04.
Artigo
Inglês
| MEDLINE | ID: mdl-28475899
2.
Overall survival with [177Lu]Lu-PSMA-617 versus cabazitaxel in metastatic castration-resistant prostate cancer (TheraP): secondary outcomes of a randomised, open-label, phase 2 trial.
Lancet Oncol
; 25(1): 99-107, 2024 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-38043558
3.
[177Lu]Lu-PSMA-617 plus enzalutamide in patients with metastatic castration-resistant prostate cancer (ENZA-p): an open-label, multicentre, randomised, phase 2 trial.
Lancet Oncol
; 25(5): 563-571, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38621400
4.
A phase II trial of nivolumab followed by ipilimumab and nivolumab in advanced non-clear-cell renal cell carcinoma.
BJU Int
; 133 Suppl 3: 57-67, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-37986556
5.
Pembrolizumab plus lenvatinib as first-line therapy for advanced non-clear-cell renal cell carcinoma (KEYNOTE-B61): a single-arm, multicentre, phase 2 trial.
Lancet Oncol
; 24(8): 881-891, 2023 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37451291
6.
ProNGF Expression and Targeting in Glioblastoma Multiforme.
Int J Mol Sci
; 24(2)2023 Jan 13.
Artigo
Inglês
| MEDLINE | ID: mdl-36675126
7.
[177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial.
Lancet
; 397(10276): 797-804, 2021 02 27.
Artigo
Inglês
| MEDLINE | ID: mdl-33581798
8.
Chemoradiotherapy with concurrent durvalumab for the palliative treatment of oligometastatic oesophageal and gastrooesophageal carcinoma with dysphagia: a single arm phase II clinical trial (PALEO, sponsored by the Australasian Gastro-Intestinal Trials Group).
BMC Cancer
; 22(1): 1324, 2022 Dec 17.
Artigo
Inglês
| MEDLINE | ID: mdl-36528772
9.
Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies.
Clin Microbiol Rev
; 33(3)2020 06 17.
Artigo
Inglês
| MEDLINE | ID: mdl-32522746
10.
Safety and Efficacy of Atezolizumab in Understudied Populations with Pretreated Urinary Tract Carcinoma: Subgroup Analyses of the SAUL Study in Real-World Practice.
J Urol
; 206(2): 240-251, 2021 08.
Artigo
Inglês
| MEDLINE | ID: mdl-33835866
11.
ENZA-p trial protocol: a randomized phase II trial using prostate-specific membrane antigen as a therapeutic target and prognostic indicator in men with metastatic castration-resistant prostate cancer treated with enzalutamide (ANZUP 1901).
BJU Int
; 128(5): 642-651, 2021 11.
Artigo
Inglês
| MEDLINE | ID: mdl-34028967
12.
Business as unusual: medical oncology services adapt and deliver during COVID-19.
Intern Med J
; 51(5): 673-681, 2021 05.
Artigo
Inglês
| MEDLINE | ID: mdl-34047023
13.
Stem/progenitor cell marker expression in clear cell renal cell carcinoma: a potential relationship with the immune microenvironment to be explored.
BMC Cancer
; 20(1): 272, 2020 Apr 03.
Artigo
Inglês
| MEDLINE | ID: mdl-32245446
14.
The precursor for nerve growth factor (proNGF) is not a serum or biopsy-rinse biomarker for thyroid cancer diagnosis.
BMC Endocr Disord
; 19(1): 128, 2019 Nov 27.
Artigo
Inglês
| MEDLINE | ID: mdl-31775768
15.
The Precursor for Nerve Growth Factor (proNGF) in Thyroid Cancer Lymph Node Metastases: Correlation with Primary Tumour and Pathological Variables.
Int J Mol Sci
; 20(23)2019 Nov 25.
Artigo
Inglês
| MEDLINE | ID: mdl-31775361
16.
Patterns of response to anti-PD-1 treatment: an exploratory comparison of four radiological response criteria and associations with overall survival in metastatic melanoma patients.
Br J Cancer
; 115(10): 1186-1192, 2016 Nov 08.
Artigo
Inglês
| MEDLINE | ID: mdl-27701388
17.
Efficient generation of patient-matched malignant and normal primary cell cultures from clear cell renal cell carcinoma patients: clinically relevant models for research and personalized medicine.
BMC Cancer
; 16: 485, 2016 07 16.
Artigo
Inglês
| MEDLINE | ID: mdl-27422173
18.
Drug repurposing in oncology.
Lancet Oncol
; 21(12): e542, 2020 12.
Artigo
Inglês
| MEDLINE | ID: mdl-33271099
19.
Phenotypic heterogeneity and instability of human ovarian tumor-initiating cells.
Proc Natl Acad Sci U S A
; 108(16): 6468-73, 2011 Apr 19.
Artigo
Inglês
| MEDLINE | ID: mdl-21451132
20.
Tolerability of Olaparib Combined with Abiraterone in Patients with Metastatic Castration-resistant Prostate Cancer: Further Results from the Phase 3 PROpel Trial.
Eur Urol Oncol
; 2024 Apr 05.
Artigo
Inglês
| MEDLINE | ID: mdl-38582650